Education
About Us
Working with TipRanks
Follow Us
Pascal Biosciences Inc (TSE:NEVI)
:NEVI
RESEARCH TOOLSreports
Total Valuation
Pascal Biosciences Inc has a market cap or net worth of C$2.58M. The enterprise value is C$2.99M.
Market CapC$2.58M
Enterprise ValueC$2.99M
Share Statistics
Pascal Biosciences Inc has 39,662,727 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding39,662,727
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Pascal Biosciences Inc’s return on equity (ROE) is -0.30 and return on invested capital (ROIC) is -12.55%.
Return on Equity (ROE)-0.30
Return on Assets (ROA)-0.18
Return on Invested Capital (ROIC)-12.55%
Return on Capital Employed (ROCE)-0.15
Revenue Per Employee775.01K
Profits Per Employee-181.24K
Employee Count2
Asset Turnover0.76
Inventory Turnover1.43
Valuation Ratios
The current PE Ratio of {name} is {pe}. {name}’s PEG ratio is {priceToEarningsGrowthRatio}.
PE Ratio―
PS Ratio0.00
PB Ratio2.00
Price to Fair Value3.28
Price to FCF95.62
Price to Operating Cash Flow177.71
PEG Ratio-0.35
Income Statement
In the last 12 months, Pascal Biosciences Inc had revenue of 1.55M and earned -362.48K in profits. Earnings per share was -0.01.
Revenue1.55M
Gross Profit1.08M
Operating Income-220.15K
Pretax Income-362.48K
Net Income-362.48K
EBITDA-48.07K
Earnings Per Share (EPS)-0.01
Cash Flow
In the last 12 months, operating cash flow was 14.51K and capital expenditures 12.46K, giving a free cash flow of 26.96K billion.
Operating Cash Flow14.51K
Free Cash Flow26.96K
Free Cash Flow per Share<0.01
Dividends & Yields
Pascal Biosciences Inc pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.29
52-Week Price Change-50.00%
50-Day Moving Average0.06
200-Day Moving Average0.08
Relative Strength Index (RSI)44.25
Average Volume (3m)36.35K
Important Dates
Pascal Biosciences Inc upcoming earnings date is Oct 17, 2025, TBA (Confirmed).
Last Earnings DateJul 15, 2025
Next Earnings DateOct 17, 2025
Ex-Dividend Date―
Financial Position
Pascal Biosciences Inc as a current ratio of 1.08, with Debt / Equity ratio of 36.24%
Current Ratio1.08
Quick Ratio0.51
Debt to Market Cap0.13
Net Debt to EBITDA-8.29
Interest Coverage Ratio-3.50
Taxes
In the past 12 months, Pascal Biosciences Inc has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Pascal Biosciences Inc EV to EBITDA ratio is -92.01, with an EV/FCF ratio of -33.49.
EV to Sales2.85
EV to EBITDA-92.01
EV to Free Cash Flow-33.49
EV to Operating Cash Flow-36.71
Balance Sheet
Pascal Biosciences Inc has C$51.30K in cash and marketable securities with C$467.82K in debt, giving a net cash position of C$416.52K billion.
Cash & Marketable SecuritiesC$51.30K
Total DebtC$467.82K
Net CashC$416.52K
Net Cash Per ShareC$0.01
Tangible Book Value Per Share>-C$0.01
Margins
Gross margin is 61.78%, with operating margin of -14.20%, and net profit margin of -23.39%.
Gross Margin61.78%
Operating Margin-14.20%
Pretax Margin-23.39%
Net Profit Margin-23.39%
EBITDA Margin-3.10%
EBIT Margin-19.32%
Analyst Forecast
The average price target for Pascal Biosciences Inc is ―, which is 11.43% higher than the current price. The consensus rating is Hold
Price Target―
Price Target Upside―
Analyst ConsensusHold
Analyst Count0
Revenue Growth Forecast5.31%
EPS Growth Forecast41.57%